Login / Signup

Differences in the location of bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: A study in the World Health Organization's pharmacovigilance database.

Jean-Louis MontastrucSamuel TessierAlessandra Bura-Riviere
Published in: British journal of clinical pharmacology (2023)
This real-life study shows that the differences in bleeding locations between DOAC and VKA are not limited to the brain or gastrointestinal tracts. Significant differences were also found between Xa and thrombin inhibitors.
Keyphrases
  • direct oral anticoagulants
  • atrial fibrillation
  • venous thromboembolism
  • adverse drug
  • white matter
  • multiple sclerosis